Severe cholestasis due to disseminated histoplasmosis under adalimumab-containing immunosuppressive therapy.
作者： Berend J. van Welzen , Karel J. van Erpecum , Pieter-Jan A. Haas , Fiebo J. ten Kate , Tania Mudrikova
DOI: 10.1016/J.CLINRE.2013.03.008
关键词:
摘要:
sci-hub.se 参考文章(5)
MV Cano, Rana A Hajjeh, The epidemiology of histoplasmosis: a review. Seminars in Respiratory Infections. ,vol. 16, pp. 109- 118 ,(2001) , 10.1053/SRIN.2001.24241
L. Joseph Wheat, Histoplasmosis: a review for clinicians from non-endemic areas Mycoses. ,vol. 49, pp. 274- 282 ,(2006) , 10.1111/J.1439-0507.2006.01253.X
R. S. Wallis, M. S. Broder, J. Y. Wong, M. E. Hanson, D. O. Beenhouwer, Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists Clinical Infectious Diseases. ,vol. 38, pp. 1261- 1265 ,(2004) , 10.1086/383317
Stefan Ehlers, Tumor Necrosis Factor and Its Blockade in Granulomatous Infections: Differential Modes of Action of Infliximab and Etanercept? Clinical Infectious Diseases. ,vol. 41, ,(2005) , 10.1086/429998
J. Cuellar‐Rodriguez, R. K. Avery, M. Lard, M. Budev, S. M. Gordon, N. K. Shrestha, D. van Duin, M. Oethinger, S. D. Mawhorter, Histoplasmosis in Solid Organ Transplant Recipients: 10 Years of Experience at a Large Transplant Center in an Endemic Area Clinical Infectious Diseases. ,vol. 49, pp. 710- 716 ,(2009) , 10.1086/604712